Insider Transactions in Q2 2022 at Precision Biosciences Inc (DTIL)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 22
2022
|
John Alexander Kelly Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
33,784
+22.3%
|
$33,784
$1.5 P/Share
|
|
Jun 08
2022
|
Dario Scimeca General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
9,833
-23.22%
|
$19,666
$2.06 P/Share
|
|
Jun 08
2022
|
Derek Jantz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
18,849
-0.46%
|
$37,698
$2.06 P/Share
|
|
Jun 07
2022
|
Shane Barton VP & Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
6,061
+41.01%
|
-
|
|
Jun 07
2022
|
John Alexander Kelly Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
47,728
+23.32%
|
-
|
|
Jun 07
2022
|
Dario Scimeca General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
31,774
+29.08%
|
-
|
|
Jun 07
2022
|
Derek Jantz Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,744
+0.51%
|
-
|
|
Apr 27
2022
|
Alan List Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,775
-29.86%
|
$15,550
$2.1 P/Share
|
|
Apr 26
2022
|
Alan List Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,035
+50.0%
|
-
|